Cognitive Behavioral Treatment of Pediatric Trichotillomania

Trichotillomania Clinical Trial

Official title:

Cognitive Behavioral Treatment of Pediatric Trichotillomania

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00043563
• Other study ID #: R21MH061457
• Secondary ID: R21MH061457DSIR
• Status: Completed
• Phase: N/A
• First received: August 9, 2002
• Last updated: December 15, 2015
• Start date: January 2001
• Est. completion date: October 2004

Study information

• Verified date: December 2015
• Source: University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

This study will compare the effectiveness of cognitive-behavior therapy (CBT) to a minimal attention control (AC) condition for treatment of pediatric trichotillomania (TTM).

Description:

TTM is a persistent impulse control disorder in which the individual acts on urges to pull out his or her own hair. Onset typically occurs by adolescence, and TTM is often associated with significant functional impairment and distress. CBT is a type of psychotherapy designed to change problematic behaviors and thinking. It includes self-monitoring of hair-pulling urges and homework assignments to practice the use of cognitive and behavioral strategies.

Participants are assigned randomly to receive either CBT or AC for 8 weeks. Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks; participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks. After 8 weeks, CBT participants who respond to treatment enter Phase II, which lasts an additional 8 weeks and includes 4 in-person maintenance sessions. AC participants who are still symptomatic after 8 weeks are offered CBT.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: October 2004
• Est. primary completion date: October 2004
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 8 Years to 17 Years

Eligibility

Inclusion Criteria:

• Primary diagnosis of Trichotillomania

• Minimum symptom duration of 6 months

• Presence of a stable parent or guardian

Exclusion Criteria:

• Other primary psychiatric diagnosis

• Bipolar illness, pervasive developmental disorder, thought disorder, current major depression, ADD/ADHD

• Concurrent psychotherapy

• Currently receiving psychotropic medications

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Trichotillomania

Intervention

Behavioral:
• Cognitive-Behavior Therapy

Locations

Country	Name	City	State
United States	Center for the Treatment and Study of Anxiety	Philadelphia	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
University of Pennsylvania	National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	National Institute of Mental Health (NIMH) Trichotillomania Severity Scale	Semi-structured interview about hair-pulling and related symptoms	1 week	No